Nalu Neurostimulation System for Peripheral Nerve Stimulation
Stimulator, Peripheral Nerve, Implanted (Pain Relief). 510(k) K232415, from Boston Scientific Neuromodulation (Valencia, CA). Product code GZF, class 2.
As of Nov 21, 2026, K232415 is an FDA 510(k) held by Boston Scientific Neuromodulation, substantially equivalent on Aug 21, 2024 after 376 days, with no recalls tied to it in FDA's recall database.
- Review time: 376 days
- Recalls: 0
This system is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. The system is not intended to treat pain in the craniofacial region.
- Nalu Neurostimulation Kit (Integrated, 40 cm: Single 8/Dual 8), Nalu Neurostimulation Kit (Ported, 2 cm: Single 8/Dual…K183579 · Boston Scientific Neuromodulation · Mar 29, 2019
- Nalu Neurostimulation SystemK203547 · Boston Scientific Neuromodulation · Mar 25, 2021
- StimTrial Neuromodulation SystemK253877 · Bioventus, LLC · Aug 26, 2026
- StimTrial Neuromodulation SystemK243782 · Bioventus, LLC · Jul 16, 2025
- TalisMann Neuromodulation SystemK243678 · Bioventus, LLC · Jul 3, 2025
- Freedom Peripheral Nerve Stimulator (PNS) SystemK233162 · Curonix · Jun 20, 2024
- Neuspera Nuity SystemK221303 · Neuspera Medical, Inc. · Apr 11, 2023
- StimRouter Neuromodulation SystemK211965 · Bioness, Inc. · Feb 23, 2022
- Neuspera Neurostimulation System (NNS)K202781 · Neuspera Medical, Inc. · Aug 27, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 11, 2023
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5870
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files